Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Cecilia Quarracino, Matilde Otero-Losada, Francisco Capani & Santiago Pérez-Lloret. (2020) State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson’s disease. Expert Opinion on Pharmacotherapy 21:4, pages 445-457.
Read now
Read now
Dinkar Kulshreshtha, Jacky Ganguly & Mandar Jog. (2020) Managing autonomic dysfunction in Parkinson’s disease: a review of emerging drugs. Expert Opinion on Emerging Drugs 25:1, pages 37-47.
Read now
Read now
Santiago Pérez-Lloret, Cecilia Quarracino, Matilde Otero-Losada & Olivier Rascol. (2019) Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases. Expert Opinion on Pharmacotherapy 20:6, pages 635-645.
Read now
Read now
Arina Madan, Sudeshna Ray, Daniel Burdick & Pinky Agarwal. (2017) Management of lower urinary tract symptoms in Parkinson's disease in the neurology clinic. International Journal of Neuroscience 127:12, pages 1136-1149.
Read now
Read now
Santiago Perez-Lloret. (2016) Investigational drugs for autonomic dysfunction in Parkinson’s disease. Expert Opinion on Investigational Drugs 25:3, pages 259-262.
Read now
Read now
Roberto Erro, Gabriella Santangelo, Paolo Barone & Carmine Vitale. (2015) Nonmotor symptoms in Parkinson's disease: classification and management. Journal of Parkinsonism and Restless Legs Syndrome 5, pages 1-10.
Read now
Read now
Malco Rossi, Marcelo Merello & Santiago Perez-Lloret. (2015) Management of constipation in Parkinson’s disease. Expert Opinion on Pharmacotherapy 16:4, pages 547-557.
Read now
Read now
Santiago Perez-Lloret, María Verónica Rey, Anne Pavy-Le Traon & Olivier Rascol. (2014)
Droxidopa for the treatment of neurogenic orthostatic hypotension and other symptoms of neurodegenerative disorders. Expert Opinion on Orphan Drugs 2:5, pages 509-522.
Read now
Read now
Articles from other publishers (18)
Sunil Yadav, Munindra Kumar Singh & Saurabh Pal. (2023) Artificial Intelligence Model for Parkinson Disease Detection Using Machine Learning Algorithms. Biomedical Materials & Devices.
Crossref
Crossref
Xu Dong-Chen, Chen Yong, Xu Yang, ShenTu Chen-Yu & Peng Li-Hua. (2023) Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Alessandra Consonni, Martina Miglietti, Chiara Maria Giulia De Luca, Federico Angelo Cazzaniga, Arianna Ciullini, Ilaria Linda Dellarole, Giuseppe Bufano, Alessio Di Fonzo, Giorgio Giaccone, Fulvio Baggi & Fabio Moda. (2022) Approaching the Gut and Nasal Microbiota in Parkinson’s Disease in the Era of the Seed Amplification Assays. Brain Sciences 12:11, pages 1579.
Crossref
Crossref
Rahul & Yasir Siddique. (2022) Neurodegenerative Disorders and the Current State, Pathophysiology, and
Management of Parkinson’s Disease. CNS & Neurological Disorders - Drug Targets 21:7, pages 574-595.
Crossref
Crossref
Debbie Duncan. (2021) Role of the community nurse in Parkinson's disease and lower urinary disorders. British Journal of Community Nursing 26:5, pages 251-254.
Crossref
Crossref
Shen-Yang Lim, Ai Huey Tan & Mathis Grossmann. 2021. Clinical Trials In Parkinson's Disease. Clinical Trials In Parkinson's Disease
367
377
.
Janis M. Miyasaki. 2019. Neuropalliative Care. Neuropalliative Care
59
72
.
Benjamin M. Brucker & Sidhartha Kalra. (2017) Parkinson’s Disease and Its Effect on the Lower Urinary Tract. Urologic Clinics of North America 44:3, pages 415-428.
Crossref
Crossref
Werner Poewe, Klaus Seppi, Caroline M. Tanner, Glenda M. Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag & Anthony E. Lang. (2017) Parkinson disease. Nature Reviews Disease Primers 3:1.
Crossref
Crossref
Ryuji Sakakibara, Jalesh Panicker, Enrico Finazzi-Agro, Valerio Iacovelli & Homero Bruschini. (2016) A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders. Neurourology and Urodynamics 35:5, pages 551-563.
Crossref
Crossref
. 2016. Parkinson's Disease. Parkinson's Disease
93
174
.
Santiago Perez-Lloret & Francisco J Barrantes. (2016) Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease. npj Parkinson's Disease 2:1.
Crossref
Crossref
Andrée-Anne Poirier, Benoit Aubé, Mélissa Côté, Nicolas Morin, Thérèse Di Paolo & Denis Soulet. (2016) Gastrointestinal Dysfunctions in Parkinson’s Disease: Symptoms and Treatments. Parkinson's Disease 2016, pages 1-23.
Crossref
Crossref
Giovanni Palleschi & Yazan Al Salhi. 2016. Functional Urologic Surgery in Neurogenic and Oncologic Diseases. Functional Urologic Surgery in Neurogenic and Oncologic Diseases
163
170
.
Santiago Perez-Lloret, Olivier Flabeau, Pierre-Olivier Fernagut, Anne Pavy-Le Traon, María Verónica Rey, Alexandra Foubert-Samier, Francois Tison, Olivier Rascol & Wassilios G. Meissner. (2015) Current Concepts in the Treatment of Multiple System Atrophy. Movement Disorders Clinical Practice 2:1, pages 6-16.
Crossref
Crossref
Anand V. Badri, Rajveer S. Purohit, Jason Skenazy, Jeffrey P. Weiss & Jerry G. Blaivas. (2014) A Review of Lower Urinary Tract Symptoms in Patients with Parkinson?s Disease. Current Urology Reports 15:9.
Crossref
Crossref
Arif Dalvi, Kelly E. Lyons & Rajesh Pahwa. 2014. Inflammation in Parkinson's Disease. Inflammation in Parkinson's Disease
1
24
.
Santiago Perez-Lloret, María Verónica Rey, Anne Pavy-Le Traon & Olivier Rascol. (2013) Orthostatic hypotension in Parkinson’s disease. Neurodegenerative Disease Management 3:4, pages 363-377.
Crossref
Crossref